• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

Kelly Blackburn Appointed Bach Pharma CEO


July 18, 2016

Bach Pharma Inc. (North Andover, MA) has appointed Kelly Blackburn as Chief Executive Officer.

Kelly Blackburn

Ms. Blackburn was previously Vice President of Clinical Affairs at aTyr Pharma (San Diego, CA). Prior to that she was at Vertex Pharmaceuticals.

Ms. Blackburn is tasked with leading Bach Pharma as it brings its lead candidate, GVT, into the clinic.  

The company also announced that Mark O. Henry will serve as Chief Financial Officer, transitioning from his role as CEO. 


Related Videos
Related Content